Vimarsana
Biggest News Aggregation in the World

Page 14 - Abstracts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abstracts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abstracts Today - Breaking & Trending Today

Mirum Pharmaceuticals to Showcase LIVMARLI® (maralixibat) Data at EASL and ESPGHAN Annual Congresses - Vimarsana News

Mirum Pharmaceuticals to Showcase LIVMARLI® (maralixibat) Data at EASL and ESPGHAN Annual Congresses

- Eight abstracts accepted, including three oral presentations - Maralixibat data highlighting predictors of event-free survival in patients with Alagille syndrome nominated for prestigious Alex... | June 13, 2022

Indivior Announces Seven Abstracts Accepted for Presentation at the 84th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD) - Vimarsana News

Indivior Announces Seven Abstracts Accepted for Presentation at the 84th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD)

RICHMOND, Va., June 9, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the acceptance of seven abstracts for presentation at the 84th Annual Scientific Meeting of the College on

Recordati Rare Diseases Inc.: Recordati Rare Diseases Announces Several Scientific Abstracts to Be Presented at the Upcoming Endo Society Annual Meeting - Vimarsana News

Recordati Rare Diseases Inc.: Recordati Rare Diseases Announces Several Scientific Abstracts to Be Presented at the Upcoming Endo Society Annual Meeting

Recordati Rare Diseases Inc. announced today that various scientific abstracts have been accepted and will be presented onsite at the ENDO 2022 annual meeting being held in Atlanta, Georgia from June

PathAI To Present Three Abstracts at International Liver Congress 2022 - Vimarsana News

PathAI To Present Three Abstracts at International Liver Congress 2022

AI-powered pathology leader announces novel continuous scoring system for fibrosis that may be accurate and predictive of patient progression as company doubles down on commitment to changing the standard

Enterome to present three abstracts on its novel OncoMimics cancer immunotherapies at ASCO 2022 - Vimarsana News

Enterome to present three abstracts on its novel OncoMimics cancer immunotherapies at ASCO 2022

World first clinical data of EO2401, Enterome's first-in-class off-the-shelf OncoMimics therapeutic cancer vaccine, to be presented PARIS, May 27, 2022 /PRNewswire/ -- Enterome, a clinical